NewsRx

Search our medical news database

Transplantation

Enhanced Engraftment of Hematopoietic Progenitors

Published in Gene Therapy Weekly, June 3rd, 1996

Low level irradiation following growth factor preconditioning enhances engraftment of hematopoietic progenitors.

There are several genetic disorders whereby low-level, long-term engraftment of gene therapy corrected stem cells could mean a cure. However, to date there have been only moderate successes in engraftment of enough modified hematopoietic progenitor cells (HPCs) to sustain a cure.

Michael Mardiney III and Harry L. Malech of the U.S. National Institutes of Health, showed that by using a progenitor enriched fraction of marrow from untreated mouse donors into congenic recipients that even very low-dose radiation conditioning of the recipient...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook